Published on March 22, 2007
EXHIBIT
23.2
Consent
of Independent Registered Public Accounting Firm
We
hereby
consent to the incorporation by reference in the Registration Statement on
(Form S-8 No. 333-59490) pertaining to the 2000 Stock Option Plan of
eXegenics Inc., formerly Cytoclonal Pharmaceutics, Inc., and the Registration
Statement (Form S-8 No. 333-86201) pertaining to the 1996 Stock Option Plan
of eXegenics Inc., and related prospectuses of our report dated
February 18, 2005, except for Notes K and N which are as of
April 12, 2005, with respect to the 2004 financial statements of eXegenics
Inc. included in the Annual Report (Form 10-K) for the year ended
December 31, 2006.
BDO
Seidman, LLP
Dallas,
Texas
March
22,
2007